Researchers at UT Southwestern Medical Center have determined that light reflectance spectroscopy can differentiate between malignant and benign prostate tissue with 85 percent accuracy, a finding that may lead to real-time ...
Feb 26, 2016
0
2
(HealthDay)—For men with localized prostate cancer undergoing radical prostatectomy, serum 25-hydroxyvitamin D (25-OH D) insufficiency/deficiency is associated with increased odds of adverse pathology, according to a study ...
Feb 24, 2016
0
36
Patients who have undergone radical prostatectomy often have largely unrealistic expectations with regard to their postoperative sexual function, new research shows.
Jan 4, 2016
0
0
Older black men with localized prostate cancer were more likely to have poorer quality care, incur higher costs and have worse postoperative outcomes than white men but that did not translate to worse overall or cancer-specific ...
Oct 22, 2015
0
11
A recent study reported in The Journal of Nuclear Medicine compared use of the novel Ga-68-PSMA-ligand PET/CT with other imaging methods and found that it had substantially higher detection rates of prostate-specific membrane ...
May 4, 2015
0
10
Despite strong evidence and guidelines supporting its use, post-surgical radiation therapy for prostate cancer patients at risk of recurrence is declining in the United States. The study, published online in the journal European ...
Apr 20, 2015
0
5
A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels indicate their cancer has ...
Mar 11, 2015
0
9
(HealthDay)—Considerable practice variation exists among surgeons at a high-volume academic center when selecting patients with prostate cancer to undergo radical prostatectomy, according to a study published in the March ...
Feb 16, 2015
0
4
Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a study published in the February ...
Feb 5, 2015
0
15
(HealthDay)—Phosphodiesterase type 5 inhibitor use after radical prostatectomy is associated with increased risk of biochemical recurrence, according to a study published in the February issue of The Journal of Urology.
Jan 29, 2015
0
6
